Borderline Breast Phyllodes Tumor Coexisting with Intermediate- Grade Ductal Carcinoma In Situ and Focal Invasion: A Case Report and Literature Review

Abstract Introduction: Borderline phyllodes tumor (PT) coexisting with ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) is an exceptionally rare mixed breast lesion. Due to its low incidence and compositional complexity, it poses substantial diagnostic and management challenges. We present such a case to highlight the pitfalls in preoperative diagnosis and the rationale for a multidisciplinary therapeutic strategy. Presentation of case: A 72-year-old Chinese female presented with a 2-week history of a right breast mass. Ultrasound and mammography revealed a large (52.6 mm), well-circumscribed, lobulated solid mass (BI-RADS 4A/4B), suggestive of a phyllodes tumor. Core needle biopsy returned “fibroadenoma with usual ductal hyperplasia.” Subsequent lumpectomy showed borderline PT (80%), intermediate-grade DCIS (20%), and focal Grade II invasive carcinoma of no special type (< 1%, maximal invasive diameter 3 mm). Immunohistochemistry of the invasive component: ER(−), PR(−), HER-2(3+), Ki-67 60%. Given the patient’s preference against breast conservation, a right total mastectomy with sentinel lymph node biopsy was performed (0/1 nodes positive). Final staging: pT1aN0M0, Stage IA, HER-2 overexpression subtype. No adjuvant chemotherapy, targeted therapy, or radiotherapy was given. At 12-month follow-up, no local or distant recurrence was observed. Conclusion Definitive diagnosis of PT coexisting with DCIS and IDC relies on adequate excision specimens rather than biopsy alone. Clinical management should integrate PT behavior with standard breast cancer guidelines through multidisciplinary collaboration, balancing complete oncologic control against the risk of overtreatment. Longer follow-up is warranted to confirm durable outcomes.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11351131/v1
Primary Topic
Breast Lesions and Carcinomas
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Borderline Breast Phyllodes Tumor Coexisting with Intermediate- Grade Ductal Carcinoma In Situ and Focal Invasion: A Case Report and Literature Review

Xuewen Xiao, Huiyang Tang, Kang He, Dongmin Yu et al.
Research Square
Breast Lesions and Carcinomas
preprint

Borderline Breast Phyllodes Tumor Coexisting with Intermediate- Grade Ductal Carcinoma In Situ and Focal Invasion: A Case Report and Literature Review

Xuewen Xiao, Huiyang Tang, Kang He, Dongmin Yu, Haiyang Guan, Yongzhen Li, Lulin Liu, Shihui Huang, Kelin Xu
preprint en

Abstract

Abstract Introduction: Borderline phyllodes tumor (PT) coexisting with ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) is an exceptionally rare mixed breast lesion. Due to its low incidence and compositional complexity, it poses substantial diagnostic and management challenges. We present such a case to highlight the pitfalls in preoperative diagnosis and the rationale for a multidisciplinary therapeutic strategy. Presentation of case: A 72-year-old Chinese female presented with a 2-week history of a right breast mass. Ultrasound and mammography revealed a large (52.6 mm), well-circumscribed, lobulated solid mass (BI-RADS 4A/4B), suggestive of a phyllodes tumor. Core needle biopsy returned “fibroadenoma with usual ductal hyperplasia.” Subsequent lumpectomy showed borderline PT (80%), intermediate-grade DCIS (20%), and focal Grade II invasive carcinoma of no special type (< 1%, maximal invasive diameter 3 mm). Immunohistochemistry of the invasive component: ER(−), PR(−), HER-2(3+), Ki-67 60%. Given the patient’s preference against breast conservation, a right total mastectomy with sentinel lymph node biopsy was performed (0/1 nodes positive). Final staging: pT1aN0M0, Stage IA, HER-2 overexpression subtype. No adjuvant chemotherapy, targeted therapy, or radiotherapy was given. At 12-month follow-up, no local or distant recurrence was observed. Conclusion Definitive diagnosis of PT coexisting with DCIS and IDC relies on adequate excision specimens rather than biopsy alone. Clinical management should integrate PT behavior with standard breast cancer guidelines through multidisciplinary collaboration, balancing complete oncologic control against the risk of overtreatment. Longer follow-up is warranted to confirm durable outcomes.

Research Square
Gannan Medical University (CN), First Affiliated Hospital of Gannan Medical University (CN)
National Natural Science Foundation of China, Health Commission of Jiangxi Province, Gannan Medical University
Good health and well-being
Breast Lesions and Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon